Skip to content
Clinical Trials – home
FinlandBack to Finland

Clinical trials in Seinajoki

33 clinical trials in Seinajoki, Finland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

FinlandOur site in FinlandKliinisetTutkimukset.fi(opens in a new tab)
Seinajoki at a glance
33
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

33 trials in Seinajoki

Open in trial search
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH
Countries:FinlandFinland
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:GROUP B STREPTOCOCCUS CAPSULAR POLYSACCHARIDE IB CONJUGATED TO DIPHTHERIA TOXIN CRM197
  • Sponsor:Pfizer Inc.
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Iohexol
  • Sponsor:University Of Helsinki
Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:HUS-yhtymae
Countries:FinlandFinland
  • Participants:18–64 years
  • Substances:Benzylpenicillin Sodium
  • Sponsor:University Of Oulu
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Vigabatrin
  • Sponsor:HUS-yhtymae
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Pirkanmaan hyvinvointialue
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Sponsor:Sanofi Pasteur Inc.
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:HUMAN METAPNEUMOVIRUS, VIRUS-LIKE PROTEIN
  • Sponsor:AstraZeneca AB
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
  • Sponsor:Pfizer Inc.

Influenza+1

Not yet recruiting
Registered drug
Countries:FinlandFinland
  • Participants:65+ years · Healthy volunteers
  • Substances:INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED
  • Sponsor:GlaxoSmithKline Biologicals

Pneumococcal immunisation

Not yet recruiting
Registered drug
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
  • Sponsor:Pfizer Inc.

Other cities in Finland

The busiest research cities in the country

All 28 cities in Finland

Clinical research in Seinajoki

What the registry says about research in the country

01 Infectious Disease Prevention

Extensive research focusing on vaccine development against multiple infectious diseases, including studies on RSV, influenza, and pneumococcal infections. Clinical trials are evaluating novel vaccination strategies for different age groups.

  • Respiratory Syncytial Virus Vaccines
  • Influenza Prevention
  • Meningococcal Protection

Multiple studies are assessing immunogenicity and safety profiles in various populations from infants to older adults.

02 Oncology Research

Innovative investigations into prostate cancer treatments, including studies on hormone therapy resistance and radiation-based interventions. Research focuses on both metastatic and non-metastatic disease states.

  • Advanced Prostate Cancer Therapies
  • Hormone Treatment Studies
  • Radiation-based Interventions

Trials are exploring combination therapies and novel treatment approaches for various stages of cancer progression.

03 Emergency Medicine

Studies examining acute medical conditions, including appendicitis management and myocardial infarction interventions. Research is focused on optimizing treatment protocols and improving patient outcomes.

  • Acute Abdomen Diagnostics
  • Cardiac Emergency Care
  • Antibiotic Treatment Protocols

Investigations are comparing traditional and innovative approaches to emergency medical conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).